Associate Professor
University of Iowa
Mark Santillan is an Associate Professor in the Department of OB/Gyn and Molecular Medicine at the University of Iowa. He is a Maternal Fetal Medicine subspecialist and physician-scientist. He completed his BS honors Chemistry, BA honors Philosophy, Medical Doctor degrees, and OB/Gyn Residency at Loyola University in Chicago, IL. He completed his PhD in Translational Biomedicine at the University of Iowa. As a board certified Maternal Fetal Medicine specialist his clinical and research interests are in hypertensive disorders in pregnancy and the immunology of pregnancy. His lab is particularly interested in the early mechanisms of maternal health during pregnancy and the short and long-term health effects to the mother and child. His NIH funded lab is investigating the predictive, preventative, therapeutic and curative potential of the vasopressin and RGS2 pathway in preeclampsia. He has extensive experience from the local to international realms in clinical cohort development from diverse sources, clinical data harmonization, and central data and biosamples management. He serves as the Clinical Translational Core Co-director for the NIH funded Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (NIH P50) as well as the Associate Director for Special Populations in the Iowa Institute for Clinical and Translational Science (NIH UL1). His expertise in Maternal-Fetal Medicine, clinical cohort management, basic/translational research, and basic immunovascular mechanisms of perinatal disease are focused on investigating perinatal disease at the basic, translational, and clinical science levels.